FLEX vs REGN
Flex Ltd (FLEX) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Flex Ltd (FLEX) is a electronic components company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported FLEX revenue for 2025-03-31 was $6.40B. Net income was $838.0M. Revenue was down 2.4% from 2024-12-31 to 2025-03-31. FLEX currently screens at market cap $18.12B and trailing P/E 23.0.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
FLEX currently screens at market cap $18.12B and trailing P/E 23.0. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the FLEX and REGN stock pages for the full models.
Not investment advice.